CS logo
small CS logo
Keystone Research Ltd.

Austin, Texas, United States
Health in Austin, Texas
5717 Balcones Dr, Austin, TX 78731

About Keystone Research Ltd.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Aerie Pharmaceuticals
2
Allergan
2
Formosa Pharmaceuticals, Inc.
2
Actavis Inc.
1
Alcon Research
1
Amneal Pharmaceuticals, LLC
1
Eyenovia Inc.
1
Glaukos Corporation
1
Kowa Research Institute, Inc.
1
QLT Inc.
1
Santen Inc.
1
Total Rows: 11

Clinical Trials at Keystone Research Ltd.


During the past decade, Keystone Research Ltd. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000022112211330000000000440011Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
2008-03-01
2008-10-01
Completed
165
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
2010-09-23
2016-08-09
Completed
109
Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation
2013-11-01
2014-07-01
Completed
43
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
2014-12-15
2019-07-19
Completed
594
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
2015-04-01
2016-05-01
Completed
973
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
2018-12-01
2019-01-21
Completed
76
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
2018-12-27
2019-07-26
Completed
261
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
2019-08-13
2020-04-07
Completed
132

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Keystone Research Ltd." #1 sponsor was "Aerie Pharmaceuticals" with 2 trials, followed by "Allergan" with 2 trials sponsored, "Formosa Pharmaceuticals, Inc." with 2 trials sponsored, "Actavis Inc." with 1 trials sponsored and "Alcon Research" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Keystone Research Ltd." #1 collaborator was "CBCC Global Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAerie Pharmaceuticals: 2Aerie Pharmaceuticals: 2Allergan: 2Allergan: 2FormosaPharmaceuticals, Inc.: 2FormosaPharmaceuticals, Inc.: 2Actavis Inc.: 1Actavis Inc.: 1Alcon Research: 1Alcon Research: 1Amneal Pharmaceuticals, LLC: 1Amneal Pharmaceuticals, LLC: 1Eyenovia Inc.: 1Eyenovia Inc.: 1Glaukos Corporation: 1Glaukos Corporation: 1Kowa Research Institute, Inc.: 1Kowa Research Institute, Inc.: 1QLT Inc.: 1QLT Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsCBCC Global Research: 1CBCC Global Research: 1

Clinical Trials Conditions at Keystone Research Ltd.


According to Clinical.Site data, the most researched conditions in "Keystone Research Ltd." are "Ocular Hypertension" (5 trials), "Glaucoma, Open-Angle" (4 trials), "Glaucoma" (2 trials), "Ocular Inflammation and Pain" (2 trials) and "Open-Angle Glaucoma" (2 trials). Many other conditions were trialed in "Keystone Research Ltd." in a lesser frequency.

Clinical Trials Intervention Types at Keystone Research Ltd.


Most popular intervention types in "Keystone Research Ltd." are "Drug" (12 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "APP13007, 0.05%" (2 trials), "0.005% latanoprost" (1 trials), "APP13007 Placebo, 0.05%" (1 trials) and "APP13007 Placebo, 0.1%" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Keystone Research Ltd.


The vast majority of trials in "Keystone Research Ltd." are 14 trials for "All" genders.

Clinical Trials Status at Keystone Research Ltd.


Currently, there are NaN active trials in "Keystone Research Ltd.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Keystone Research Ltd., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Keystone Research Ltd., 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 4Phase 2: 4Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 2Active, not recruiting: 2Recruiting: 2Recruiting: 2